Masoudi, M. et al. Metabolic adaptations in cancer stem cells: a key to therapy resistance. Biochim. Biophys. Acta Mol. Basis Dis. 1870, 167164 (2024).
Google ScholarÂ
Sancho, P., Barneda, D. & Heeschen, C. Hallmarks of cancer stem cell metabolism. Br. J. Cancer. 114, 1305–1312 (2016).
Google ScholarÂ
Hijazi, M. A., Gessner, A. & El-Najjar, N. Repurposing of chronically used drugs in cancer therapy: a chance to grasp. Cancers 15, 3199 (2023).
Google ScholarÂ
Yuen, C. A., Asuthkar, S., Guda, M. R., Tsung, A. J. & Velpula, K. K. Cancer stem cell molecular reprogramming of the Warburg effect in glioblastomas: a new target gleaned from an old concept. CNS Oncol. 5, 101–108 (2016).
Google ScholarÂ
Jiang, Z. et al. Cancer derived exosomes induce macrophages immunosuppressive polarization to promote bladder cancer progression. Cell Commun. Signal. 19, 93 (2021).
Google ScholarÂ
Milella, M. et al. The metabolic landscape of cancer stem cells: insights and implications for therapy. Cells 14, 717 (2025).
Google ScholarÂ
Paolini, L. et al. Lactic acidosis together with GM-CSF and M-CSF induces human macrophages toward an inflammatory protumor phenotype. Cancer Immunol. Res. 8, 383–395 (2020).
Google ScholarÂ
Yan, L. et al. Breast cancer stem cells secrete MIF to mediate tumor metabolic reprogramming that drives immune evasion. Cancer Res. 84, 1270–1285 (2024).
Google ScholarÂ
Bi, Q., Sun, Z. J., Wu, J. Y. & Wang, W. Ferroptosis-mediated formation of tumor-promoting immune microenvironment. Front. Oncol. 12, 868639 (2022).
Google ScholarÂ
Yang, J. et al. Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway. Stem Cells 31, 248–258 (2013).
Google ScholarÂ
Radharani, N. N. V. et al. Tumor-associated macrophage derived IL-6 enriches cancer stem cell population and promotes breast tumor progression via Stat-3 pathway. Cancer Cell Int. 22, 122 (2022).
Google ScholarÂ
Yuan, H. et al. Cancer stem cells and tumor-associated macrophages: interactions and therapeutic opportunities. Cancer Lett. 624, 217737 (2025).
Google ScholarÂ
Lu, H. et al. The breast cancer stem cell niche is supported by juxtacrine signalling from monocytes and macrophages. Nat. Cell Biol. 16, 1105–1117 (2014).
Google ScholarÂ
Manjunath, Y. et al. Tumor-cell-macrophage fusion cells as liquid biomarkers and tumor enhancers in cancer. Int. J. Mol. Sci. 21, 1872 (2020).
Google ScholarÂ
Ran, B. et al. Dynamic remodeling of amino acid metabolism in tumor-associated macrophages: fueling immunosuppression, reshaping tumor niches, and unlocking metabolic checkpoints. J. Adv. Res. S2090-1232, 00729–5 (2025).
Raychaudhuri, D. et al. Histone lactylation drives CD8+ T cell metabolism and function. Nat. Immunol. 25, 2140–2151 (2024).
Google ScholarÂ
Soula, M. et al. Glycosphingolipid synthesis mediates immune evasion in KRAS-driven cancer. Nature 633, 451–458 (2024).
Google ScholarÂ
Wei, J. R. et al. QSOX1 facilitates dormant esophageal cancer stem cells to evade immune elimination via PD-L1 upregulation and CD8 T cell exclusion. Proc. Natl Acad. Sci. USA 121, e2407506121 (2024).
Google ScholarÂ
Tharp, K. M. et al. Tumor-associated macrophages restrict CD8+ T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment. Nat. Cancer 5, 1045–1062 (2024).
Google ScholarÂ
Rodriguez, P. C. et al. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res. 64, 5839–5849 (2004).
Google ScholarÂ
Liang, J. et al. Selective deficiency of mitochondrial respiratory complex I subunits Ndufs4/6 causes tumor immunogenicity. Nat. Cancer. 6, 323–337 (2025).
Google ScholarÂ
Chi, F. et al. Dietary cysteine enhances intestinal stemness via CD8+ T cell-derived IL-22. Nature 647, 706–715 (2025).
Google ScholarÂ
Harmon, C. et al. Lactate-mediated acidification of tumor microenvironment induces apoptosis of liver-resident nk cells in colorectal liver metastasis. Cancer Immunol. Res. 7, 335–346 (2019).
Google ScholarÂ
Cai, H., Ren, Y., Chen, S., Wang, Y. & Chu, L. Ferroptosis and tumor immunotherapy: a promising combination therapy for tumors. Front. Oncol. 13, 1119369 (2023).
Google ScholarÂ
Gao, J., Zhang, X., Liu, Y. & Gu, X. Ferroptosis in immune cells: implications for tumor immunity and cancer therapy. Cytokine Growth Factor Rev. 84, 59–73 (2025).
Google ScholarÂ
Kane, K., Edwards, D. & Chen, J. The influence of endothelial metabolic reprogramming on the tumor microenvironment. Oncogene 44, 51–63 (2025).
Google ScholarÂ
Végran, F., Boidot, R., Michiels, C., Sonveaux, P. & Feron, O. Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis. Cancer Res. 71, 2550–2560 (2011).
Google ScholarÂ
Skuli, N. et al. Endothelial HIF-2α regulates murine pathological angiogenesis and revascularization processes. J. Clin. Invest. 122, 1427–1443 (2012).
Google ScholarÂ
Chen, J. et al. Glioblastoma stem cell-specific histamine secretion drives pro-angiogenic tumor microenvironment remodeling. Cell Stem Cell 29, 1531–1546 (2022).
Google ScholarÂ
Offer, S. et al. Extracellular lipid loading augments hypoxic paracrine signaling and promotes glioma angiogenesis and macrophage infiltration. J. Exp. Clin. Cancer Res. 38, 241 (2019).
Google ScholarÂ
Hisano, Y. & Hla, T. Bioactive lysolipids in cancer and angiogenesis. Pharmacol. Ther. 193, 91–98 (2019).
Google ScholarÂ
Sounni, N. E. et al. Blocking lipid synthesis overcomes tumor regrowth and metastasis after antiangiogenic therapy withdrawal. Cell Metab. 20, 280–294 (2014).
Google ScholarÂ
O’Neill, K. C., Liapis, E., Harris, B. T., Perlin, D. S. & Carter, C. L. Mass spectrometry imaging discriminates glioblastoma tumor cell subpopulations and different microvascular formations based on their lipid profiles. Sci. Rep. 12, 17069 (2022).
Google ScholarÂ
Rohlenova, K. et al. Single-cell RNA sequencing maps endothelial metabolic plasticity in pathological angiogenesis. Cell Metab. 31, 862–877 (2020).
Google ScholarÂ
Zhao, L. et al. Lymphatic endothelial-like cells promote glioblastoma stem cell growth through cytokine-driven cholesterol metabolism. Nat. Cancer 5, 147–166 (2024).
Google ScholarÂ
Draoui, N., de Zeeuw, P. & Carmeliet, P. Angiogenesis revisited from a metabolic perspective: role and therapeutic implications of endothelial cell metabolism. Open Biol. 7, 170219 (2017).
Google ScholarÂ
Chen, D. et al. Paracrine factors from adipose-mesenchymal stem cells enhance metastatic capacity through Wnt signaling pathway in a colon cancer cell co-culture model. Cancer Cell Int. 15, 42 (2015).
Google ScholarÂ
Mele, V. et al. Mesenchymal stromal cells induce epithelial-to-mesenchymal transition in human colorectal cancer cells through the expression of surface-bound TGF-β. Int. J. Cancer 134, 2583–2594 (2014).
Google ScholarÂ
Kitamura, F. et al. Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironment in pancreatic cancer. JCI Insight 8, e163022 (2023).
Google ScholarÂ
Zhang, Y. et al. HIF-1α is necessary for activation and tumour-promotion effect of cancer-associated fibroblasts in lung cancer. J. Cell. Mol. Med. 25, 5457–5469 (2021).
Google ScholarÂ
Gao, F., Sun, K., Wang, S., Zhang, X. & Bai, X. Lactate metabolism reprogramming in pdac: potential for tumor therapy. Biochim. Biophys. Acta Rev. Cancer. 1880, 189373 (2025).
Google ScholarÂ
Timaner, M. et al. Therapy-educated mesenchymal stem cells enrich for tumor-initiating cells. Cancer Res. 78, 1253–1265 (2018).
Google ScholarÂ
Forte, D. et al. Bone marrow mesenchymal stem cells support acute myeloid leukemia bioenergetics and enhance antioxidant defense and escape from chemotherapy. Cell Metab. 32, 829–843 (2020).
Google ScholarÂ
Figueroa, J. et al. Exosomes from glioma-associated mesenchymal stem cells increase the tumorigenicity of glioma stem-like cells via transfer of mir-1587. Cancer Res. 77, 5808–5819 (2017).
Google ScholarÂ
Rutledge, A., Jobling, P., Walker, M. M., Denham, J. W. & Hondermarck, H. Spinal cord injuries and nerve dependence in prostate cancer. Trends Cancer 3, 812–815 (2017).
Google ScholarÂ
Saloman, J. L. et al. Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer. Proc. Natl Acad. Sci. USA 113, 3078–3083 (2016).
Google ScholarÂ
Silverman, D. A. et al. Cancer-associated neurogenesis and nerve-cancer cross-talk. Cancer Res. 81, 1431–1440 (2021).
Google ScholarÂ
Lagadec, C. et al. Trka overexpression enhances growth and metastasis of breast cancer cells. Oncogene 28, 1960–1970 (2009).
Google ScholarÂ
Pascual, G. et al. Dietary palmitic acid promotes a prometastatic memory via Schwann cells. Nature 599, 485–490 (2021).
Google ScholarÂ
Zarco, N., Norton, E., Quiñones-Hinojosa, A. & Guerrero-Cázares, H. Overlapping migratory mechanisms between neural progenitor cells and brain tumor stem cells. Cell. Mol. Life Sci. 76, 3553–3570 (2019).
Google ScholarÂ
Venkatesh, H. S. et al. Neuronal activity promotes glioma growth through neuroligin-3 secretion. Cell 161, 803–816 (2015).
Google ScholarÂ
Venkatesh, H. S. et al. Electrical and synaptic integration of glioma into neural circuits. Nature 573, 539–545 (2019).
Google ScholarÂ
Zeng, Q. et al. Synaptic proximity enables nmdar signalling to promote brain metastasis. Nature 573, 526–531 (2019).
Google ScholarÂ
Zahalka, A. H. et al. Adrenergic nerves activate an angio-metabolic switch in prostate cancer. Science 358, 321–326 (2017).
Google ScholarÂ
Irvin, D. M., McNeill, R. S., Bash, R. E. & Miller, C. R. Intrinsic astrocyte heterogeneity influences tumor growth in glioma mouse models. Brain Pathol. 27, 36–50 (2017).
Google ScholarÂ
Matias, D. et al. Microglia/astrocytes-glioblastoma crosstalk: crucial molecular mechanisms and microenvironmental factors. Front. Cell. Neurosci. 12, 235 (2018).
Google ScholarÂ
Virtuoso, A. et al. The glioblastoma microenvironment: morphology, metabolism, and molecular signature of glial dynamics to discover metabolic rewiring sequence. Int. J. Mol. Sci. 22, 3301 (2021).
Google ScholarÂ
Zhang, H., Zhou, Y., Cui, B., Liu, Z. & Shen, H. Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma. Biomed. Pharmacother. 126, 110086 (2020).
Google ScholarÂ
Perelroizen, R. et al. Astrocyte immunometabolic regulation of the tumour microenvironment drives glioblastoma pathogenicity. Brain 145, 3288–3307 (2022).
Google ScholarÂ
Turcan, S. et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 483, 479–483 (2012).
Google ScholarÂ
Chen, L., Shi, L., Wang, W. & Zhou, Y. Abcg2 downregulation in glioma stem cells enhances the therapeutic efficacy of demethoxycurcumin. Oncotarget 8, 43237–43247 (2017).
Google ScholarÂ
Zhou, Y. et al. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts. J. Exp. Clin. Cancer Res. 37, 324 (2018).
Google ScholarÂ
Tong, Y., Ueyama-Toba, Y. & Mizuguchi, H. Biliary epithelial cell differentiation of bipotent human liver-derived organoids by 2D and 3D culture. Biochem. Biophys. Rep. 33, 101432 (2023).
Google ScholarÂ
Zhang, R. et al. Activated hepatic stellate cells secrete periostin to induce stem cell-like phenotype of residual hepatocellular carcinoma cells after heat treatment. Sci. Rep. 7, 2164 (2017).
Google ScholarÂ
Chen, G. et al. A positive feedback loop between periostin and tgfβ1 induces and maintains the stemness of hepatocellular carcinoma cells via AP-2α activation. J. Exp. Clin. Cancer Res. 40, 218 (2021).
Google ScholarÂ
Govaere, O. et al. Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche. J. Hepatol. 64, 609–617 (2016).
Google ScholarÂ
Chen, Q. T. et al. Hk1 from hepatic stellate cell-derived extracellular vesicles promotes progression of hepatocellular carcinoma. Nat. Metab. 4, 1306–1321 (2022).
Google ScholarÂ
Banales, J. M. et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat. Rev. Gastroenterol. Hepatol. 17, 557–588 (2020).
Google ScholarÂ
Clement, E. et al. Adipocyte extracellular vesicles carry enzymes and fatty acids that stimulate mitochondrial metabolism and remodeling in tumor cells. EMBO J. 39, e102525 (2020).
Google ScholarÂ
Sandforth, L. et al. Impact of the monocarboxylate transporter-1 (MCT1)-mediated cellular import of lactate on stemness properties of human pancreatic adenocarcinoma cells. Cancers 12, 581 (2020).
Google ScholarÂ
Sousa, C. M. et al. Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion. Nature 536, 479–483 (2016).
Google ScholarÂ
Liu, X. et al. The CD39–CD73–adenosine axis: master regulator of immune evasion and therapeutic target in pancreatic ductal adenocarcinoma. Biochim. Biophys. Acta Rev. Cancer. 1880, 189443 (2025).
Google ScholarÂ
Zhang, A. M. Y. et al. Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation. Cell Metab. 35, 2119–2135 (2023).
Google ScholarÂ
Nieman, K. M., Romero, I. L., Van Houten, B. & Lengyel, E. Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim. Biophys. Acta 1831, 1533–1541 (2013).
Google ScholarÂ
Nieman, K. M. et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat. Med. 17, 1498–1503 (2011).
Google ScholarÂ
Beyaz, S. et al. High-fat diet enhances stemness and tumorigenicity of intestinal progenitors. Nature 531, 53–58 (2016).
Google ScholarÂ
Wu, C., Dong, S., Huang, R. & Chen, X. Cancer-associated adipocytes and breast cancer: Intertwining in the tumor microenvironment and challenges for cancer therapy. Cancers 15, 726 (2023).
Google ScholarÂ
Xiong, X. et al. Upregulation of CPT1A is essential for the tumor-promoting effect of adipocytes in colon cancer. Cell Death Dis. 11, 736 (2020).
Google ScholarÂ
Patterson, B. W. et al. Regional muscle and adipose tissue amino acid metabolism in lean and obese women. Am. J. Physiol. Endocrinol. Metab. 282, E931–E936 (2002).
Google ScholarÂ
Rodrigues, F. S. et al. Bidirectional activation of stem-like programs between metastatic cancer and alveolar type 2 cells within the niche. Dev. Cell. 59, 2398–2413 (2024).
Google ScholarÂ
Dayton, T. L. & Clevers, H. Beyond growth signaling: paneth cells metabolically support ICSs. Cell Res. 27, 851–852 (2017).
Google ScholarÂ
Leiwe, M. & Asselin-Labat, M. L. The dynamics of the metastatic niche: lung alveolar type 2 cell reprogramming and cancer cell stemness. Dev. Cell 59, 2393–2395 (2024).
Google ScholarÂ
Li, C., Song, G., Zhang, S., Wang, E. & Cui, Z. Wnt3a increases the metastatic potential of non-small cell lung cancer cells in vitro in part via its upregulation of Notch3. Oncol. Rep. 33, 1207–1214 (2015).
Google ScholarÂ
Gschwend, J. et al. Alveolar macrophages rely on GM-CSF from alveolar epithelial type 2 cells before and after birth. J. Exp. Med. 218, e20210745 (2021).
Google ScholarÂ
Kumar, A., Taghi Khani, A., Sanchez Ortiz, A. & Swaminathan, S. GM-CSF: a double-edged sword in cancer immunotherapy. Front. Immunol. 13, 901277 (2022).
Google ScholarÂ
Little, I., Bersie, S., Redente, E. F., McCubbrey, A. L. & Tarling, E. J. Alveolar macrophages: guardians of the alveolar lipid galaxy. Curr. Opin. Lipidol. 36, 153–162 (2025).
Google ScholarÂ
Li, T., Wang, Z., Yang, H. & Kang, Y. Metabolic reprogramming in bone metastasis of human cancers. Front. Cell Dev. Biol. 13, 1711592 (2025).
Google ScholarÂ
Lemma, S. et al. MDA-MB-231 breast cancer cells fuel osteoclast metabolism and activity: a new rationale for the pathogenesis of osteolytic bone metastases. Biochim. Biophys. Acta Mol. Basis Dis. 1863, 3254–3264 (2017).
Google ScholarÂ
Zhao, Z. et al. Downregulation of MCT1 inhibits tumor growth, metastasis and enhances chemotherapeutic efficacy in osteosarcoma through regulation of the NF-κB pathway. Cancer Lett. 342, 150–158 (2014).
Google ScholarÂ
Tan, Y. et al. Cancer cachexia: molecular basis and therapeutic advances. Signal Transduct. Target. Ther. 11, 16 (2026).
Google ScholarÂ
Bonen, A. The expression of lactate transporters (MCT1 and MCT4) in heart and muscle. Eur. J. Appl. Physiol. 86, 6–11 (2001).
Google ScholarÂ
Zhang, C. et al. Methionine secreted by tumor-associated pericytes supports cancer stem cells in clear cell renal carcinoma. Cell Metab. 36, 778–792 (2024).
Google ScholarÂ
Sato, T. et al. Paneth cells constitute the niche for lgr5 stem cells in intestinal crypts. Nature 469, 415–418 (2011).
Google ScholarÂ
Shi, G., Li, Y., Shen, H., He, Q. & Zhu, P. Intestinal stem cells in intestinal homeostasis and colorectal tumorigenesis. Life Med. 3, lnae042 (2024).
Google ScholarÂ
Wen, G. M., Xu, X. Y. & Xia, P. Metabolism in cancer stem cells: targets for clinical treatment. Cells 11, 3790 (2022).
Google ScholarÂ
Lourenço, T. & Vale, N. Pharmacological efficacy of repurposing drugs in the treatment of prostate cancer. Int. J. Mol. Sci. 24, 4154 (2023).
Google ScholarÂ
Abbott, K. L. et al. Nutrient requirements of organ-specific metastasis in breast cancer. Nature 649, 1292–1301 (2026).
Google ScholarÂ
Padrão, N. et al. Fasting boosts breast cancer therapy efficacy via glucocorticoid activation. Nature 649, 1013–1021 (2026).
Google ScholarÂ
